Emmanuel Gage
Interventional Pain Medicine · Brunswick, GANPI 1720213093
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (58.4%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 69.4% of it on its own, with 33 other manufacturers making up the rest. 2025 is the largest year on record at $153,283, 3.5 times the $43,257 reported in 2019. Among interventional pain medicine clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,206 payments — averaging $498.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$417K
- Si-bone, Inc.$102K
- Vertos Medical, Inc.$50K
- Vertiflex, Inc.$19K
- Alevio, LLC$6K
- Painteq LLC$2K
- plus $5K from 28 others
Across 28 payments — averaging $1652.40 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$43K
- Vertiflex, Inc.$4K
What the payments were for
- Consulting fees$163,76627%
- Speaking & faculty fees$351,51958%
- Travel & lodging$51,4909%
- Food & beverage$33,5056%
- Education$1,5000%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 888 | $417,420 |
| Si-bone, Inc. | 112 | $101,968 |
| Vertos Medical, Inc. | 61 | $50,273 |
| Vertiflex, Inc. | 40 | $18,603 |
| Alevio, LLC | 5 | $5,785 |
| Painteq LLC | 18 | $2,436 |
| Genesys Orthopedics Systems, L.L.C. | 2 | $2,340 |
| Medtronic(2 entities) | 19 | $508 |
| Intelivation Technologies, LLC | 1 | $500 |
| Abbott | 7 | $490 |
| Stryker | 4 | $344 |
| Merit Medical Systems Inc | 2 | $196 |
| Collegium Pharmaceutical, Inc. | 7 | $120 |
| Relievant Medsystems, Inc. | 5 | $110 |
| Curonix LLC | 4 | $94 |
| Amgen(2 entities) | 5 | $79 |
| Scilex Pharmaceuticals Inc. | 3 | $57 |
| AbbVie | 3 | $50 |
| SPR Therapeutics, Inc | 2 | $49 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $43 |
| Nalu Medical, Inc. | 2 | $39 |
| Nevro Corp. | 2 | $31 |
| Saluda Medical Americas, Inc. | 1 | $26 |
| Heron Therapeutics, Inc. | 1 | $25 |
| Vertex | 1 | $23 |
| Protega Pharmaceutials Inc | 1 | $21 |
| Forte Bio-pharma LLC | 1 | $20 |
| GRT US Holding, Inc. | 1 | $20 |
| Bioventus LLC | 1 | $19 |
| Almatica Pharma LLC | 1 | $19 |
| Hikma Pharmaceuticals USA | 1 | $18 |
| Globus Medical | 1 | $18 |
| Convatec Inc. | 1 | $17 |
| Stimwave Technologies Incorporated | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IFUSE IMPLANT SYSTEM$99,553
- Superion Indirect Decompression System$94,049
- WaveWriter Alpha Prime 16$80,491
- SPECTRA WAVEWRITER$55,600
- mild Device Kit$48,266
- SUPERION$28,127
- GENERAL - THERAPIES$22,763
- Superion ISS$17,961
- WAVEWRITER ALPHA$17,024
- VERIFLEX$11,394
- GENERAL PAIN MANAGEMENT$11,017
- SICURE SACROILIAC JOINT FUSION SYSTEM$5,639
- PAINTEQ$2,097
- Watchman$1,273
- SPINEJACK$152
- PROCLAIM$150
- STAR Tumor Ablation System$131
- NA$128
- BIONIC NAVIGATOR$110
- GENERAL - STRUCTURAL HEART$109
How this compares
$601,780 in reported general payments places this provider in the 95th percentile of 129 interventional pain medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,911 | $41,123 |
| BelbucaBuprenorphine Hcl | 49 | $28,620 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 674 | $14,057 |
| Pregabalin | 549 | $8,996 |
| Gabapentin | 487 | $6,313 |
| Tizanidine Hcl | 422 | $4,950 |
| Buprenorphine | 14 | $4,062 |
| Oxycodone Hcl | 245 | $3,541 |
| Tramadol Hcl | 400 | $2,233 |
| Diclofenac Sodium | 168 | $2,127 |
| Baclofen | 169 | $1,834 |
| Mupirocin | 240 | $1,735 |
| Tramadol Hcl ErTramadol Hcl | 29 | $1,518 |
| Lidocaine | 13 | $1,101 |
| Morphine Sulfate ErMorphine Sulfate | 37 | $849 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca | $120 | $28,62049 claims |
| Hikma Pharmaceuticals USABuprenorphine, Morphine Sulfate | $18 | $4,33527 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 129 interventional pain medicine providers in Georgia.
Other interventional pain medicine in Brunswick
- Christopher BovinetBrunswick$338K
- Kevin CoyleBrunswick$19K
- Jordan TateJasper$540K
- David RosenfeldCovington$249K
- Nathan NeufeldNewnan$171K
- Ryan BudwanyLawrenceville$123K
- Alexandra MoreiraAtlanta$79K
- Sushanth BodaNewnan$55K
- Christopher AndrianoStockbridge$41K
- Guensley DelvaWaycross$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.